| mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.022 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |